Llwytho...
Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease
BACKGROUND AND OBJECTIVES: Revefenacin is a lung-selective, long-acting muscarinic antagonist indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease. The objectives of this analysis were to evaluate the pharmacokinetics of revefenacin and its major metabolite...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Pharmacokinet |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer International Publishing
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7932972/ https://ncbi.nlm.nih.gov/pubmed/33124005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-020-00938-3 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|